Meropenem Administration in Sepsis

Standard Dosing Regimen

The bolus should be administered over 30 minutes as a rapid infusion to quickly achieve therapeutic blood levels, as recommended by the Critical Care Medicine guidelines 1

Antimicrobials must be administered within 1 hour of recognizing sepsis, as emphasized by the Intensive Care Medicine and Critical Care Medicine guidelines 2, 3
If vascular access is limited, meropenem can be given via intraosseous access or intramuscularly, according to the Intensive Care Medicine guidelines 4
Loading doses are essential for beta-lactams to rapidly achieve therapeutic levels, especially after fluid resuscitation expands extracellular volume, as noted by the Critical Care Medicine guidelines 1

Monitor for signs of clinical improvement: normalization of vital signs, improved mental status, resolution of organ dysfunction, as recommended by the Intensive Care Medicine and Critical Care Medicine guidelines 2, 3
Narrow therapy once pathogen identification and sensitivities are established, according to the Intensive Care Medicine guidelines 4

Do not delay antimicrobial administration while waiting for cultures or imaging—obtain blood cultures but start antibiotics immediately, as advised by the Intensive Care Medicine guidelines 4

The maximum dose for a 30 kg patient would be 1 gram every 8 hours, based on adult dosing for severe infections, as recommended by the medical guidelines 5

Extended infusion over 3 hours may be considered if treating resistant organisms with MIC ≥ 8 mg/L, according to the medical guidelines 5
Treatment duration should be 5-7 days for most infections, guided by clinical response, as suggested by the medical guidelines 5
For patients with no identified pathogen who have recovered by day 10, treatment can be discontinued, as recommended by the Journal of Infection guidelines 6
For specific pathogens like Enterobacteriaceae, treatment should continue for 21 days, according to the Journal of Infection guidelines 6

If there is suspicion of extended-spectrum beta-lactamase (ESBL) producing organisms, meropenem remains an appropriate choice, as recommended by the Journal of Infection guidelines 6
Monitor clinical response within 48-72 hours of initiating therapy to assess effectiveness, as suggested by the medical guidelines 5

Assess clinical response within 48-72 hours of initiating therapy, as recommended by the medical guidelines 5